Fluorescence-Guided Bone Resection in Bisphosphonate-Associated Osteonecrosis of the Jaws

Purpose To date, the therapy of bisphosphonate-associated osteonecrosis of the jaws (BONJ) has been hampered by the lack of imaging modalities that enable the extent of necrosis to be visualized. This study aims to demonstrate the feasibility of tetracycline fluorescence guided bone resection in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oral and maxillofacial surgery 2009-03, Vol.67 (3), p.471-476
Hauptverfasser: Pautke, Christoph, MD, DDS, Bauer, Florian, MD, DDS, Tischer, Thomas, MD, Kreutzer, Kilian, MD, DDS, Weitz, Jochen, MD, DDS, Kesting, Marco, MD, DDS, Hölzle, Frank, MD, DDS, Kolk, Andreas, MD, DDS, Stürzenbaum, Stephen R., PhD, Wolff, Klaus-Dietrich, MD, DDS
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To date, the therapy of bisphosphonate-associated osteonecrosis of the jaws (BONJ) has been hampered by the lack of imaging modalities that enable the extent of necrosis to be visualized. This study aims to demonstrate the feasibility of tetracycline fluorescence guided bone resection in the surgical management of BONJ. Patients and Methods Following a 10-day preoperative administration of doxycycline in patients suffering from BONJ, sufficient doxycycline is incorporated into viable bone to be visualized with a certified medical lamp emitting exciting light at 400 to 460 nm. Results Viable and necrotic bone can be discriminated intraoperatively in a routine and reproducible manner by doxycycline bone fluorescence. Conclusion In the therapy of BONJ, conservative concepts are to be favored. The fact that necrotic bone can now be selectively resected signifies an improvement of the conservative surgical therapy of BONJ.
ISSN:0278-2391
1531-5053
DOI:10.1016/j.joms.2008.09.037